DMAMCL   Click here for help

GtoPdb Ligand ID: 9936

Synonyms: compound 21 [PMID: 22985027] | dimethylaminomicheliolide
Compound class: Synthetic organic
Comment: DMAMCL (dimethylaminomicheliolide) is a Michael adduct of micheliolide (a natural plant-derived guaianolide sesquiterpene lactone; PubChem CID 442279) [2]. It was originally identified for its ability to inhibit acute myelogenous leukemia (AML) stem and progenitor cells. More recently its mechanism of action has been determined [1]. It induces irreversible tetramerization of PKM2 and acts as a functional activator of PKM2 pyruvate kinase activity. This mechanism is being exploited as a potential anti-cancer therapeutic, with an orally active DMAMCL prodrug (ACT001) in early clinical trial (in Australian trial ACTRN12616000228482) in patients with advanced solid tumours, including glioblastoma multiforme (GBM).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 50.97
Molecular weight 294.21
XLogP 0.69
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[NH+](CC1C(=O)OC2C1CCC(=C1C2C(C)(O)CC1)C)C
Isomeric SMILES C[NH+](C[C@@H]1C(=O)O[C@H]2[C@H]1CCC(=C1[C@@H]2[C@](C)(O)CC1)C)C
InChI InChI=1S/C17H27NO3/c1-10-5-6-12-13(9-18(3)4)16(19)21-15(12)14-11(10)7-8-17(14,2)20/h12-15,20H,5-9H2,1-4H3/p+1/t12-,13-,14-,15-,17+/m0/s1
InChI Key ZPBIJIIQXPRJSS-WNZSCWOMSA-O
No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Low pyruvate kinase activity caused by the inactive dimeric state of PKM2 has been identified as a key mechanism for the proliferation of cancer cells within tumours. Stabilisation of PKM2 in its active tetrameric form by activators such as DMAMCL is predicted to provide clinical anti-tumour effects, based on in vitro and in vivo evidence [1-2].